Edition:
India

Sanofi India Ltd (SANO.NS)

SANO.NS on National Stock Exchange of India

4,714.35INR
3:29pm IST
Change (% chg)

Rs1.95 (+0.04%)
Prev Close
Rs4,712.40
Open
Rs4,711.75
Day's High
Rs4,758.00
Day's Low
Rs4,700.00
Volume
2,348
Avg. Vol
9,738
52-wk High
Rs4,980.00
52-wk Low
Rs3,940.00

Summary

Name Age Since Current Position

Aditya Narayan

2016 Independent Non-Executive Chairman of the Board

Lionel Guerin

2016 Chief Financial Officer, Whole-Time Director

Girish Tekchandani

2016 Compliance Officer, Company Secretary

Rajaram Narayanan

49 2018 Managing Director, Whole Time Director

A. Sood

2017 Whole Time Director

Cyril Grandchamp-Desraux

2017 Additional Director

Thomas Rouckout

2017 Additional Director

Shailesh Ayyangar

61 2017 Non-Executive Director

F. Briens

55 2011 Non-Executive Director

Rangaswamy Iyer

62 2016 Independent Director

Biographies

Name Description

Aditya Narayan

Lionel Guerin

Mr. Lionel Jean Guerin Chief Financial Officer, Whole-Time Director of the Company. Mr. Guerin was Chief Financial Officer of one of Saint-Gobain Group’s affiliates in Poland between 2000 and 2003 and then the Group’s Chief Financial Officer for Poland and Eastern Europe zone between 2003 and 2008. He was Chief Financial Officer of Sanofi Poland from June 2011.

Girish Tekchandani

Rajaram Narayanan

A. Sood

Cyril Grandchamp-Desraux

Thomas Rouckout

Shailesh Ayyangar

Dr. Shailesh Ayyangar is re-designated as Non-Executive Director of the Company effective December 31st, 2017. He is currently serves as Managing Director, Executive Director of Sanofi India Limited. He served as the Wholetime Director of Sanofi- Synthelabo (India) Limited. His qualifications are B.V.Fc & A.H., P.G.D.M. IIM (Ahmedabad). Dr. Shailesh Ayyangar assumed office as Managing Director of Aventis Pharma Limited on October 25, 2005. Dr. Ayyangar has wide-ranging experience in the pharmaceutical industry. He held senior Sales and Marketing positions in SmithKline Beecham Pharmaceuticals and GlaxoSmithKline (GSK) in India and Great Britain. He was also Wholetime Director of SmithKline Beecham Pharmaceuticals before its merger with GlaxoWellcome. He was Head of the Tropical Medicine Business unit for International Markets in SmithKline Beecham, UK, for four years prior to his return to India. A graduate in Veterinary Science, Dr. Ayyangar holds a Post-graduate Degree in Business Management from the Indian Institute of Management (IIM), Ahmedabad, Gujarat.

F. Briens

Mr. F. Briens is the Non-Executive Director of the company. Mr. Briens joined in the Sanofi Group in March 1988 as an Internal Auditor. Since then, he served in a variety of positions including Director of Controlling in the USA and CFO Interlatina Zone in Panama. After the merger with Synthelabo, he was nominated Deputy Director in the Audit department and then CFO for the Latin America Region. In January 2000, he was appointed to his current position as Vice-President, Chief Financial Officer for the Intercontinental Region of Sanofi.

Rangaswamy Iyer

Mr. Rangaswamy R. Iyer is an Independent Director of the Company. He was MD of Wyeth Limited for about ten years till end October 2009.